MyFembree hits shelves in Canada

Pfizer Canada announced today MyFembree is available to Canadian Women with Fibroids and Endometriosis. 

Few treatments are available that don't involve surgery or require invasive commitments, making MyFembree the most exciting progress for chronic uterine conditions in years.  

"For many fibroid and endometriosis patients, symptoms can be debilitating. These conditions progress for years, while women are simultaneously managing jobs and families," said Patricia Lee, Founder of CANFib (Canadian Women with Fibroids). "MYFEMBREE being added to Canada's toolbox means women with endometriosis and uterine fibroids have much-needed access to new treatment options for their symptoms." (more at Newswire)